Sort
17,288 grants matching “multiple sclerosis”
Development of Immunological Reagents for the Identification of New World Monkey Biomarkers
$155,323Luis David Giavedoni · Trinity University · R24 · FY2023 · OD
Novel visual outcome measures in optic neuritis and multiple sclerosis
$155,279Laura J Balcer · University Of Pennsylvania · K24 · FY2008 · EY
USING QUANTITATIVE TRAITS TO IDENTIFY NOVEL GENES FOR ALZHEIMERS DISEASE AND OTHER COMPLEX TRAITS
$155,250Carlos Cruchaga · Washington University · RF1 · FY2018 · AG
EPIGALLOCATECHIN GALLATE AS A NEUROPROTECTANT IN A MODEL OF MULTIPLE SCLEROSIS
$155,188Gail H Marracci · Oregon Health & Science University · R21 · FY2007 · AT
Development of Advanced MRI for the Thoracolumbar Spinal Cord for Clinical Application
$155,146Kristin Poole O'Grady · Vanderbilt University Medical Center · K01 · FY2020 · EB
Training in Methods of Computational Neuroscience
$154,838William S. Reznikoff · Marine Biological Laboratory · R25 · FY2013 · MH
Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity
$154,569Deanna L Kroetz · University Of California, San Francisco · R01 · FY2023 · CA
Identification of compounds that activate interferon to treat viral infections
$154,500Luis Martinez-Sobrido · University Of Rochester · R21 · FY2011 · NS
Harnessing biomaterials to study the link between local lymph node function and systemic tolerance
$154,472Christopher M Jewell · Univ Of Maryland, College Park · R01 · FY2021 · EB
Failure of Axon Repair in Chronic MS Lesions
$154,375Stanford University · R01 · FY2003 · NS
Failure of Axon Repair in Chronic MS Lesions
$154,375Stanford University · R01 · FY2004 · NS
SUPRASPINAL TARGETS IN NEUROGENIC VOIDING DYSFUNCTION
$154,275Rose Khavari · Methodist Hospital Research Institute · K23 · FY2018 · DK
Measuring communicative participation in adults with communication disorders
$154,274Carolyn Rae Baylor · University Of Washington · R03 · FY2010 · DC
"ASIC1a-activated Signaling Pathways in Neurons"
$154,139Zhigang Xiong · Morehouse School Of Medicine · U54 · FY2015 · NS
Nicotine/Cannabinoid Therapy for Alzheimer's Disease
$154,063R. Douglas Shytle · University Of South Florida · R21 · FY2007 · AG
Costimulation Genes and Pathways in Type 1 Diabetes
$154,047Brigham And Women'S Hospital · P01 · FY2005 · AI
Therapeutic Inhibition of MIF to Improve Glucocorticoid Response
$154,035Karen G. Anthony · L2 Diagnostics, Llc · R43 · FY2019 · AI
A chemical biology approach to drug TREM2, an undruggable target in innate immunity
$154,000Thomas Sterling Scanlan · Oregon Health & Science University · R56 · FY2021 · DK
Chemical and genetic screens for modulators of nervous system development and myelination
$154,000Kelly R Monk · Oregon Health & Science University · R01 · FY2017 · HD
Diffusion Imaging of Axonal Loss in the Optic Nerves
$153,974Robert T Naismith · Washington University · K23 · FY2008 · NS
Depolarization-induced Ca Stores Release in CNS Axons
$153,900Ottawa Health Research Institute · R01 · FY2003 · NS
Depolarization-induced Ca Stores Release in CNS Axons
$153,900Ottawa Health Research Institute · R01 · FY2005 · NS
Depolarization-induced Ca Stores Release in CNS Axons
$153,900Ottawa Health Research Institute · R01 · FY2004 · NS
Investigation and Treatment of Ocular Motor Disorders
$153,799Richard John Leigh · Case Western Reserve University · R01 · FY2006 · EY
High-Impact Trials Center: Collaborative Opportunities Component
$153,758Gary R Cutter · University Of Alabama At Birmingham · P2C · FY2015 · HD